| Abstract A025: KAT6A/B and Menin-MLL complexes coordinately regulate estrogen receptor-driven gene expression programs in breast cancer SN Olsen, B Anderson, C Hatton, R Jeselsohn, M Brown, E Toska, ... Molecular Cancer Therapeutics 23 (6_Supplement), A025-A025, 2024 | | 2024 |
| Abstract PR012: KAT6A/B and Menin-MLL complexes coordinately regulate estrogen receptor-driven gene expression programs in breast cancer SN Olsen, B Anderson, C Hatton, R Jeselsohn, M Brown, E Toska, ... Molecular Cancer Therapeutics 23 (6_Supplement), PR012-PR012, 2024 | | 2024 |
| Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate Cancer A Neeb, I Figueiredo, D Bogdan, L Cato, J Stober, JM Jiménez-Vacas, ... Molecular cancer therapeutics 23 (6), 791-808, 2024 | 1 | 2024 |
| Developing culturally responsive school leaders in Ireland and Spain. The evolving role of professional development L Sancho, M Brown, S Gardezi, J O’Hara, MJ Rodríguez-Conde Irish Educational Studies, 1-22, 2024 | | 2024 |
| Defining androgen receptor function and the effects of PARP inhibition in BRCA1/2-deficient vs. proficient prostate cancer NA Traphagen, E Wheeler, R Li, X Qiu, M Brown Cancer Research 84 (6_Supplement), 6285-6285, 2024 | | 2024 |
| Chemoproteomic evaluation of PROTACs targeting estrogen receptor alpha for ER+ breast cancer Z Sandusky, M Brown Cancer Research 84 (6_Supplement), 6577-6577, 2024 | | 2024 |
| Obesity promotes breast cancer progression via complement 1q T Zhang, S Liu, M Brown Cancer Research 84 (6_Supplement), 7461-7461, 2024 | | 2024 |
| Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes VB Venkadakrishnan, AG Presser, R Singh, MA Booker, NA Traphagen, ... Research Square, 2024 | | 2024 |
| Cholesterol biosynthesis inhibition synergizes with AKT inhibitors in triple-negative breast cancer AL Hillis, TD Martin, HE Manchester, JM Hogstrom, N Zhang, E Lecky, ... | | 2024 |
| Increased chromatin accessibility mediated by nuclear factor I drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancer L Poluben, M Nouri, J Liang, A Varkaris, B Ersoy-Fazlioglu, ... bioRxiv, 2024.01. 10.575110, 2024 | | 2024 |
| Transcription factor dynamics, oscillation, and functions in human enteroendocrine cell differentiation PNP Singh, W Gu, S Madha, AW Lynch, P Cejas, R He, S Bhattacharya, ... Cell Stem Cell, 2024 | 2 | 2024 |
| Cistrome Data Browser: integrated search, analysis and visualization of chromatin data L Taing, A Dandawate, S L’Yi, N Gehlenborg, M Brown, CA Meyer Nucleic Acids Research 52 (D1), D61-D66, 2024 | 9 | 2024 |
| Cholesterol biosynthesis inhibition synergizes with AKT inhibitors in triple-negative breast cancer A Toker, AL Hillis, TD Martin, HE Manchester, JM Hogstrom, N Zhang, ... bioRxiv, 2024.01. 16.575899, 2024 | | 2024 |
| Heterogeneity and transcriptional drivers of triple-negative breast cancer B Jovanović, D Temko, LE Stevens, M Seehawer, A Fassl, K Murphy, ... Cell reports 42 (12), 2023 | 1 | 2023 |
| TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence G Wu, N Yoshida, J Liu, X Zhang, Y Xiong, TB Heavican-Foral, E Mandato, ... Science translational medicine 15 (714), eadi7244, 2023 | 2 | 2023 |
| Multi-batch single-cell comparative atlas construction by deep learning disentanglement AW Lynch, M Brown, CA Meyer Nature Communications 14 (1), 4126, 2023 | 4 | 2023 |
| Biomarkers predictive of endocrine resistance in breast cancer X Liu, M Brown, W Li, X Tengfei US Patent 11,685,954, 2023 | 2 | 2023 |
| scATAnno: automated cell type annotation for single-cell ATAC sequencing data Y Jiang, Z Hu, AW Lynch, J Jiang, A Zhu, Z Zeng, Y Zhang, G Wu, Y Xie, ... bioRxiv, 2023.06. 01.543296, 2023 | 1 | 2023 |
| MetaTiME integrates single-cell gene expression to characterize the meta-components of the tumor immune microenvironment Y Zhang, G Xiang, AY Jiang, A Lynch, Z Zeng, C Wang, W Zhang, J Fan, ... Nature communications 14 (1), 2634, 2023 | 5 | 2023 |
| Abstract LB202: Obesity-trained C1q+ macrophages compromiseT cell anti-tumor immunity T Zhang, S Liu, M Brown Cancer Research 83 (8_Supplement), LB202-LB202, 2023 | | 2023 |
Xiaole Shirley LiuCEO, GV20 Therapeutics在 ds.dfci.harvard.edu 的电子邮件经过验证
